Memorial Sloan Kettering Commack - Limited Protocol Activities

Commack, New York 11725

13 studies enrolling now · 39 studies all time

What they study most

Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL), Bladder Cancer, Brain Tumor, Breast Cancer, Breast Carcinoma, Central Nervous System Lymphoma, Clinical Stage: Stage II (T3-4, N-), Colorectal Adenocarcinoma, Colorectal Cancer, ER+ Breast Cancer, Esophageal Cancer, Esophageal Neoplasms

Studies at this site

• Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers — Recruiting now
• A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma — Recruiting now
• A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL) — Recruiting now
• A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer — Recruiting now
• A Study of Sotorasib in People With Brain Tumors — Recruiting now
• Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors — Recruiting now
• Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment — Recruiting now
• Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery — Recruiting now
• A Study of Ruxolitinib and Duvelisib in People With Lymphoma — Recruiting now
• A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer — Recruiting now
• A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy — Recruiting now
• A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST) — Recruiting now
• A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer — Recruiting now
• Researching the Effect of Exercise on Cancer — Running, not enrolling
• A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma — Running, not enrolling
• A Study of MCARH109 and MCARH125 in People With Multiple Myeloma — Running, not enrolling
• A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer — Running, not enrolling
• Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer — Completed
• A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer — Running, not enrolling
• Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment — Running, not enrolling
• High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma — Running, not enrolling
• A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones — Completed
• Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma — Running, not enrolling
• A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer — Running, not enrolling
• A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer — Running, not enrolling
• A Study of the Use of Text Message Reminders to Take Palbociclib — Running, not enrolling
• Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors — Completed
• A Study of Amivantamab in People With Esophagogastric Cancer — Running, not enrolling
• Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL) — Completed
• Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors — Running, not enrolling
• Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) — Completed
• Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy — Completed
• Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer — Running, not enrolling
• A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide — Running, not enrolling
• Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma — Completed
• Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer — Completed
• A Study of Pembrolizumab and Cryoablation in People With Mesothelioma — Completed
• Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma — Stopped early
• A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection — Stopped early